Genetic features of Mexican women predisposing to cancer of the uterine cervix

Human Pathology

Volumn 30, Issue 6, 1999, Pages 626-628

  Silva, Beatriz ^b   Vargas Alarcón, Gilberto ^b   Zúñiga Ramos, Joaquín ^b   Rodríguez Reyna, Tatiana Sofía ^b   Hernández Martinez, Betina ^b   Osnaya, Norma ^b   Kofman, Susana ^b   Torres Lobatón, Alfonso ^b   Granados, Julio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b NONE

Author keywords

Cervical carcinoma; HLA; Major histocompatibility complex (MHC)

Indexed keywords

HLA DR1 ANTIGEN; HLA DR5 ANTIGEN; HLA DR6 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CAUCASIAN; CONSANGUINITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEXICO; PHENOTYPE; UTERINE CERVIX CANCER;

EID: 0032993172     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90085-0     Document Type: Article

References (36)

1. Compendio de información epidemiológica de cancer 1982-1988. Dirección General de Epidemiología, México 18-21, 1991
2. Parkin DM, Lara E, Muir CS: Estimates of the wordwide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184-197, 1988
3. Southern SA, Herrington CS: Molecular events in uterine cervical cancer. Sex Transm Infect 74: 101-9, 1998
4. Trowsdale J, Powis S: The MHC relationship between linkage and function. Genet Dev 2: 492-97, 1992
5. Duncan Campbell R, Trowsdale J: Map of the human MHC. Immunol Today 14: 349-352, 1993
6. Cowland J, Andersen V, Halberg P, et al: DNA polymorphism of HLA class II genes in Sistemic Lupus Erythematosus. Tissue Antigens 43: 34-37, 1994
7. Nepom G, Nepom B: The Major Histocompatibility Complex, in Klippel J, Dieppl P (ed): Rheumatology. St Louis, Mosby, 1994, pp 12.1-12.12
8. Lee JE, Lowy AM, Thomson WA, et al: Association of gastric adenocarcinoma with the HLA class II gene DQB1*0301. Gastroenterology 11: 426-32, 1996
9. Ogoshi K, Tajima T, Mitomi T, et al: HLA antigens are candidate markers for prediction of limph node metastasis in gastric cancer. Clin Exp Metastasis 14: 277-81, 1996
10. Wank R, Thomssen C: High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352: 723-25, 1991
11. Syrjanen K, Nurmi T, Mantyjarvi R, et al: HLA Types in Women with Cervical Human Papillomavirus (HPV) Lesions Prospectively Followed up for 10 Years. Cytopathology 7: 99-107, 1996
12. Nawa A, Nishiyama Y, Kobayashi T, et al: Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer 75: 518-21, 1995
13. Glew S, Stern P: HLA antigens and cervical carcinoma. Nature 356: 22-24, 1992
14. Odunsi K, Terry G, Ho L, et al: Association between HLA-DQB1*03 and cervical intra-epitelial neoplasia. Mol-Med 1: 161-71, 1995
15. Helland A, Olsen AO, Gjoen K, et al: An increased risk of cervical intra-epitelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: A population-based case-control study of Norwegian women. Int J Cancer 76: 19-24, 1998
16. Sanjeevi CB, Hjelmstrom P, Hallmans G, et al: Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 68: 409-14, 1996
17. Sastre-Garau X, Loste MN, Vincent-Salomon A, et al: Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 69: 159-64, 1996
18. Duggan-Keen MF, Keating PJ, Stevens FR, et al: Immunogenetic factors in HPV-associated cervical cancer: Influence on disease progression. Eur J Immunogenet 23: 275-84, 1996
19. Lisker R, Pérez-Briceño R, Granados J, et al: Gene frequencies and admixture estimates in a mexican city population. Am J Physical Anthropol 71: 203-7, 1986
20. Lisker R, Pérez-Briceño R, Granados J, et al: Gene frequencies and admixture estimates in the State of Puebla, Mexico. Am J Physical Anthropol 76: 331-5, 1988
21. Lisker R, Ramírez E, Pérez-Briceño R, et al: Gene frequencies and admixture estimates in four Mexican Urban Centers. Hum Biol 62: 791-801, 1990
22. Weckman AL, Vargas-Alarcón G, López M, et al: Frequency of HLA-A, and HLA-B alleles in a Mexico City Mestizo group. Am J of Hum Biol 9: 1-5, 1997
23. de Leo C, Castelán N, López M, et al: HLA class I and class II alleles and haplotypes in Mexican Mestizos established form serological typing of 50 families. Hum Biol 69: 809-818, 1997
24. Boyum A: Isolation of leucocytes from human blood: further observations. Scand J Clin Lab Invest Sppl 97: 31, 1968
25. Terasaki PI, Bernoco DD, Park MS, et al: Microdroplet testing for HLA-A, B, C and D antigens. Am J Clin Pathol 69: 103-120, 1978
26. Terasaki PI, Mc Clelland JD: Microdoplet assay of human serum cytotoxins. Nature 204: 998, 1964
27. Bodmer JG, Pickbornie P, Richard S: Ia serology, in Bodmer WF, Batchelor JR, Bodmer JG, et al (eds): Histocompatibility Testing, Munksgaard, Copenhagen 35, 1977.
28. Chen L, Linsley PS, Hellstrom KE: Co-stimulation of T cells for tumor immunity. Immunol Today 14: 483-86, 1993
29. Gómez-Casado E, Vargas-Alarcón G, Martínez-Laso J, et al: Generation of the HLA-B35, -B5, -B16, and B15 groups of alleles studied by intron 1 and 2 sequence analysis. Immunogenetics 46: 469-476, 1997
30. Vargas-Alarcón G, Martínez-Laso J, Granados J, et al: Description of a Novel HLA-B35 (B*3514) Allele found in a Mexican Family of Nahua Aztec Descent. Hum Immunol 45: 148-151, 1996
31. Vargas-Alarcón G, Alvarez M, Martínez-Laso J, et al: A new HLA-B35 (B*3516) allele found in a Mexican of Nahua (Aztec) descent. Immunogenetics 43: 244-245, 1996
32. Vargas-Alarcón G, Martínez-Laso J, Gómez-Casado E, et al: A novel HLA-B35 (B*3517) allele found in a Mexican of Otomi descent. Tissue Antigens 47: 547-550, 1996
33. Garrido F, Cabrera T, Concha A, et al: Natural history of HLA expression during tumor development. Inmunol Today 14: 491-99, 1993
34. Van-Driel WJ, Tjiong MY, Hilders CG, et al: Association of allele-specific HLA expression and histopatologic progression of cervical carcinoma. Gynecol-Oncol 62: 33-41, 1996
35. Santin AD, Hermonat P, Ravaggi A, et al: Effects of retinoic acid combined with interferon-gamma on the expression of Major Histocompatibility Complex molecules and intercellular adhesion molecule-1 in human cervical cancer. Int J Cancer 75: 254-8, 1998
36. Allen M, Kalantari M, Ylitalo N, et al: HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 48: 32-7, 1996